News › Pharmaceuticals  ·  22 Jun 2026, 3:16 PM IST  ·  24 days ago

Bullish Signal: Laurus Labs, Biocon Eyed for MSCI India Inclusion

VolatileBias: Bullish +6390% confidencePharmaceuticalsAutomotiveBullish read

In one line — Focus on long positions in high-probability inclusion candidates like LAURUSLABS and BIOCON, with a short-term to medium-term horizon, while being cautious on SBICARD.

Bearish
Bullish
−1000+63+100

Source: Economic Times · AI-summarised by Anadi · Updated 22 Jun 2026, 3:41 PM IST

Pharmaceuticalstilt positive
Automotivetilt positive
Metals & Miningtilt positive
Financial Servicestilt positive

What Happened

JM Financial has identified several Indian companies as potential candidates for inclusion or exclusion from the MSCI India Standard Index. Laurus Labs and Biocon are high-probability additions, while Ather Energy and SAIL are medium-probability candidates. Conversely, SBI Card faces a high probability of exclusion. These changes are expected to trigger approximately $3.2 billion in passive fund inflows into the Indian market.

Why It Matters (for you)

MSCI index rebalancing events are significant for the Indian market as they dictate the allocation of passive funds, which track these indices. Inclusions lead to mandatory buying by these funds, creating demand and often driving up stock prices, while exclusions result in selling pressure. The estimated $3.2 billion inflow indicates a substantial liquidity event for the market.

Impact on Indian Markets

Laurus Labs (LAURUSLABS) and Biocon (BIOCON) are likely to see increased buying interest from passive funds, potentially leading to upward price momentum. SAIL (SAIL) could also benefit. SBI Card (SBICARD) faces selling pressure due to its high probability of exclusion. The broader pharmaceutical and potentially the EV/mobility sectors (due to Ather Energy) could see positive sentiment, while financial services might experience mixed signals.

What Traders Should Watch Next

Traders should monitor official MSCI announcements regarding the rebalancing, typically made a few weeks before implementation. Observe the price action of the identified stocks, especially Laurus Labs and Biocon, for pre-inclusion accumulation. For SBI Card, watch for increased selling volume. Also, keep an eye on overall FII/DII flows as a broader indicator of market sentiment around these events.

Key Evidence

  • JM Financial predicts significant shifts in MSCI India Standard Index.
  • Laurus Labs and Biocon are high-probability inclusion candidates from Small Cap Index.
  • Ather Energy and SAIL are medium-probability inclusion candidates.
  • SBI Card faces a high probability of exclusion.
  • Potential changes could lead to estimated $3.2 billion in passive fund inflows into India.